The Friday Report is our regular update (currently monthly) with a summary of the key papers, analyses and data that we’ve looked at recently. In Friday Report 72 we look at:
- Autumn booster campaign progress – over 10m now boosted
- Effectiveness of vaccines and prior infection against Omicron
- Vaccine developments – nasal (AZ), bivalent (Pfizer and Moderna)
- Protection conferred by prior COVID-19 infection
- Variants – BA.5 remains dominant but BQ.1 is on the rise
- Evusheld is now available privately – at a price
- Long COVID analysis
- ONS infectivity statistics
- Excess deaths remain high
- Hospital admissions have fallen
And finally, a novel way to combat methane emissions over in New Zealand …